Skip to main content

Refractory or Recurrent Ascites

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sequana Medical
Sequana MedicalGermany - Munich
1 program
1
ALFApump removal of ascitesPhase 31 trial
Active Trials
NCT01528410Completed58Est. Sep 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Sequana MedicalALFApump removal of ascites

Clinical Trials (1)

Total enrollment: 58 patients across 1 trials

NCT01528410Sequana MedicalALFApump removal of ascites

ALFApump System Versus Standard of Care in Ascites Treatment

Start: Aug 2012Est. completion: Sep 201658 patients
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.